GlassScriptPhysician profile
Tara Gettins
NPI 1023600152
$3,314.90
in general payments reported to CMS, 2019-2025
17 companies · $923 in 2025
The $923 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $305 · 2023: $718 · 2024: $1,156 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,777 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,776.80 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $929.23 | 2021-2025 | Lokelma, Farxiga |
| Vifor Pharma, INC. | $633.70 | 2022-2025 | Veltassa |
| Otsuka America Pharmaceutical, INC. | $539.98 | 2022-2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $347.53 | 2022-2025 | |
| Galderma Laboratories, L.P. | $234.02 | 2024 | Dysport |
| Amgen INC. | $142.83 | 2023-2025 | Krystexxa, Tavneos, Repatha |
| Novo Nordisk INC | $136.07 | 2025 | Ozempic |
| Horizon Therapeutics Plc | $67.26 | 2023 | Krystexxa |
| Calliditas Therapeutics US INC. | $64.64 | 2023-2025 | Tarpeyo |
| Ani Pharmaceuticals, INC. | $50.07 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $45.81 | 2025 | Acthar |
| Ardelyx, INC. | $28.36 | 2025 | Ibsrela |
| Novartis Pharmaceuticals Corporation | $23.78 | 2025 | |
| Lilly USA, LLC | $22.96 | 2024 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.72 | 2023 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.44 | 2025 | |
| Scpharmaceuticals INC. | $13.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Gettins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.